UF Biostatistician at the Forefront of Groundbreaking Childhood Leukemia Drug Trial
A clinical trial co-designed by UF researcher found that adding blinatumomab to chemotherapy significantly reduced relapse risk in children with acute lymphoblastic leukemia, marking a major breakthrough in treatment.
